US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
TScan Therapeutics Inc (TCRX)
TScan Therapeutics Inc (TCRX) ニュース

TCRX

TScan Therapeutics (TCRX)

TScan Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TCRX

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/13	20 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TCRX	TScan Therapeutics Inc
2024/05/13	20 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2024/05/13	20 : 00	GlobeNewswire Inc.	TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:TCRX	TScan Therapeutics Inc
2024/05/09	20 : 00	GlobeNewswire Inc.	TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/25	05 : 05	GlobeNewswire Inc.	TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/25	00 : 03	GlobeNewswire Inc.	TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/23	06 : 01	GlobeNewswire Inc.	TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/19	23 : 05	GlobeNewswire Inc.	TScan Therapeutics Announces Closing of Upsized Public Offering	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/17	13 : 30	GlobeNewswire Inc.	TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/17	05 : 25	GlobeNewswire Inc.	TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/17	05 : 01	GlobeNewswire Inc.	TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/08	21 : 00	GlobeNewswire Inc.	TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/02	20 : 00	GlobeNewswire Inc.	TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:TCRX	TScan Therapeutics Inc
2024/03/07	06 : 11	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:TCRX	TScan Therapeutics Inc
2024/03/07	06 : 05	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TCRX	TScan Therapeutics Inc
2024/03/06	21 : 30	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:TCRX	TScan Therapeutics Inc
2024/03/06	21 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2024/02/15	06 : 45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TCRX	TScan Therapeutics Inc
2024/01/29	21 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2023/12/11	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2023/12/07	21 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2023/11/09	21 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TCRX	TScan Therapeutics Inc
2023/11/09	21 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2023/08/29	21 : 02	Dow Jones News	TScan Gets FDA Clearance of Investigational New Drug Application for Cancer Treatment	NASDAQ:TCRX	TScan Therapeutics Inc
2023/08/10	20 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TCRX	TScan Therapeutics Inc
2023/08/10	20 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2023/07/25	08 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TCRX	TScan Therapeutics Inc
2023/07/25	08 : 31	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:TCRX	TScan Therapeutics Inc
2023/06/29	21 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TCRX	TScan Therapeutics Inc
2023/06/29	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:TCRX

1 2 3 4 5 次へ >>

CoastalSouth Bancshares (QX)

Leverage Shares 2x Micro...

BMO US High Dividend Cov...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約